Home›Stock Screener›Novateor Research Laboratories

Novateor Research Laboratories Share Price Today | Stock Price & Novateor Research Laboratories Share Screener

NOVATEOR Personal Products

Track the current Novateor Research Laboratories share price and stock price live with TickJournal's free stock screener. Track Novateor Research Laboratories marketcap in USD to gauge the company's total market size. Use the Novateor Research Laboratories stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Novateor Research Laboratories opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Novateor Research Laboratories Market Cap ₹19.36 Cr.
NOVATEOR P/E Ratio (TTM) -
Novateor Research Laboratories P/B Ratio 1.76
EPS (TTM) ₹0.17
Dividend Yield -
Debt to Equity 0.09
NOVATEOR 52 Week High -
Novateor Research Laboratories 52 Week Low -
Operating Margin -39.00%
Profit Margin -
NOVATEOR Revenue (TTM) -
EBITDA -
Net Income -
Total Assets ₹14.00
Total Equity ₹12.00

Novateor Research Laboratories Share Price Chart

Track the current stock price of Novateor Research Laboratories with an interactive chart. Analyse NOVATEOR share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Novateor Research Laboratories stock quote in one place.

Novateor Research Laboratories Company Profile - Fundamental Screener

Screen Novateor Research Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for NOVATEOR shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the FMCG sector and the Personal Products industry, and it trades under ISIN INE08JY01013.

Company Details

Classification

Sector FMCG
Industry Personal Products
Sub-Sector Personal Products
Segment E

Identifiers and Leadership

ISIN INE08JY01013

Novateor Research Laboratories Balance Sheet Screener

Screen NOVATEOR balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹14, up from ₹13 in 2025.

Latest statistics put total assets at ₹14 and shareholder funds at ₹12, with a leverage ratio of 0.09.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 14 13 11 9 8 9 9 4 2 2
Current Assets 0 0 0 0 0 0 0 0 0 0
Fixed Assets 3 3 2 2 2 3 4 4 2 2

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 0 0 1 0 0 0 0 0 1 1
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 12 11 9 8 8 9 9 4 1 1
Share Capital 6 5 5 5 5 5 5 3 0 0
Reserves & Surplus 6 3 4 3 3 4 4 1 1 1

Novateor Research Laboratories Income Statement Screener - Profit & Revenue Analysis

Screen Novateor Research Laboratories income statement and profit fundamentals. Analyze NOVATEOR quarterly results. Novateor Research Laboratories reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹0 and net profit was ₹0, at an operating margin of -39%.

In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹4 and net profit of ₹0.

Item None-None 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March

Revenue and Expenses

Revenue 0 4 3 2 2 1 1 1 1 0 0 0 0
Expenses 0 4 3 2 2 1 1 1 0 0 0 0 0

Operating Costs and Margins

EBITDA 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Profit % -39.00% -3.00% -5.00% -27.00% -28.00% -25.00% -176.00% -35.00% 71.00% 59.00% 42.00% -6.00% 2.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0

Profit and Earnings

Profit Before Tax 0 0 0 0 0 0 0 0 0 0 0 0 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Profit 0 0 0 0 0 0 0 0 0 0 0 0 0
EPS 0.00 0.17 0.17 0.06 0.08 -0.47 0.02 -0.02 0.74 0.18 -0.62 0.05 0.30

Novateor Research Laboratories Cash Flow Screener - Liquidity Fundamentals

Screen NOVATEOR cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹0.

Over the same period, investing activities used ₹1 and financing activities provided ₹1.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 0 -1 -1 -1 -1 0 -3 0 0 0
Investing Activities -1 0 0 0 1 0 0 -2 0 0

Financing and Net Cash

Financing Activities 1 1 1 1 0 0 4 2 0 0
Net Cash Flow 0 0 0 0 0 0 1 0 0 0

Novateor Research Laboratories Shareholding Pattern Screener

See Novateor Research Laboratories shareholding pattern with promoter, FII, and DII holdings. Check Novateor Research Laboratories promoter holding and ownership changes for NOVATEOR on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Sept, promoters held 50.75%, foreign institutions 0.00%, domestic institutions 0.00% and the public 28.91%, spread across 171 shareholders.

The shareholder count was 171 in 2026-Sept, compared with 172 in 2026-Mar.

Item 2026-Sept 2026-Mar 2025-Sept 2025-Mar 2024-Sept 2024-Mar 2023-Sept 2023-Mar

Promoter Holding

Promoter Holding 50.75% 50.75% 50.90% 51.60% 60.87% 60.87% 60.87% 60.87%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 28.91% 30.00% 29.90% 29.11% 26.52% 27.14% 26.89% 26.52%
Other Holding 20.33% 19.24% 19.19% 19.29% 12.61% 11.99% 12.24% 12.61%
Shareholder Count 171 172 172 164 160 122 118 113

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Novateor Research Laboratories. Novateor Research Laboratories dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Novateor Research Laboratories.

Novateor Research Laboratories Stock Index Membership - Nifty & Sensex

See which indices include Novateor Research Laboratories stock. Check NOVATEOR index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Novateor Research Laboratories is not part of any tracked indices.
Only major market indices are tracked in our system.

Novateor Research Laboratories Market Events Screener - Corporate Actions

Get Novateor Research Laboratories corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Novateor Research Laboratories stock events that may affect NOVATEOR share price, along with derivatives, futures and options activity and sector gainers.

10 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 14, 2026, with a record date of November 14, 2026.

It is followed by Annual General Meeting dated September 29, 2026 and Quarterly Result Announcement dated May 30, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-14 2026-11-14 Quarterly Result Announcement NA -18.60%
2026-09-29 2026-09-29 Annual General Meeting NA 17.19%
2026-05-30 2026-05-30 Quarterly Result Announcement NA 0.00%
2025-11-14 2025-11-14 Quarterly Result Announcement NA 0.00%
2025-09-30 2025-09-30 Annual General Meeting NA -22.17%
2025-05-30 2025-05-30 Quarterly Result Announcement NA 0.00%
2024-11-14 2024-11-14 Quarterly Result Announcement NA -2.01%
2024-09-28 2024-09-28 Annual General Meeting NA -1.82%
2024-07-20 2024-07-20 Extraordinary General Meeting NA 8.57%
2023-12-03 2023-12-03 Extraordinary General Meeting NA -11.67%

Novateor Research Laboratories Competitors Screener - Peer Stocks Comparison

Screen NOVATEOR competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the FMCG sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Godrej Consumer Products 91,535 46.10 15,444 7.90% 1,862 62.59
Dabur India 68,173 33.70 13,792 5.18% 1,869 53.66
Cupid 49,194 287.20 391 92.62% 108 61.90
Colgate Palmolive 46,773 34.00 6,124 -0.89% 1,325 51.70
Gillette 23,131 33.80 3,127 38.21% 654 43.23
P&G Hygiene and Health Care 22,685 28.80 4,333 27.00% 857 47.75
Emami 18,010 24.10 3,865 -0.33% 775 67.53
Mamaearth 16,882 57.70 2,476 15.37% 200 71.12
Bajaj Consumer Care 5,415 21.60 1,192 19.13% 190 45.04
Anondita Medicare 2,009 57.50 138 79.38% 34 56.50

Novateor Research Laboratories Company Announcements - News & Reports Screener

Screen NOVATEOR latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 17, 2026.

The next most recent announcements are dated November 17, 2026 and November 6, 2026.

Date Update Actions
2026-11-17 Unaudited Financial Results For The Half Year Ended On 30.09.2026 -
2026-11-17 Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial Results For The Half Year Ended On September 30 2026 -
2026-11-06 Board Meeting Intimation for Adoption Of Unaudited Financial Results For The Half Year Ended On September 30 2026 -
2026-10-16 Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements -
2026-10-15 Non Applicability Of Disclosure Under Regulation 23(9) Of SEBI (LODR) Regulations 2015 -
2026-10-15 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-10-01 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-30 Closure of Trading Window -
2026-09-29 Announcement under Regulation 30 (LODR)-Change in Registered Office Address -
2026-09-29 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-05 Reg. 34 (1) Annual Report. -
2026-09-05 Notice Of 15Th Annual General Meeting Of The Company -
2026-09-03 The Cut Off Date To Determine Eligible Shareholders Who Can Attend The 15Th Annual General Meeting Of The Company -
2026-09-03 15Th Annual General Meeting Of The Company -
2026-09-03 Appointment Of Secretarial Auditor And Internal Auditor Of The Company. -
2026-09-03 Board Meeting Outcome for Outcome Of Board Meeting Of The Board Of Directors Held On Thursday September 03 2026 -
2026-08-31 Board Meeting Intimation for Approval Of Agenda Related To Ensuing AGM And Other Businesses With The Permission Of Chairman -
2026-08-20 The Company Has Entered Into Marketer And Manufacturing Agreement With Smart Laboratories Private Limited -
2026-08-15 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-06-15 Launch Of New Product- Smiloshine Herbafresh Toothpaste Formulated With 8 Herbs 6 Grams Sachet -

Frequently Asked Questions

How is the company valued right now?

The P/B ratio is 1.76. Market capitalisation stands at ₹19.36 Cr. The company operates in the FMCG sector, in the Personal Products industry, so compare these ratios with its sector peers in the table above.

About This Data

Key statistics were last updated on November 19, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.